3730 news items
Page 4 of 100
twrhjrfcvf6n1qivtcq1azpg4irn1h xcfwj3ol8hf7f7v
BNTX
GMAB
1 Jun 24
on Form 6-K for the period ended March 31, 2024 and in subsequent filings made by BioNTech with the SEC, which are available on the SEC's website
ibha8 elqf1ukay
BDTX
1 Jun 24
.Five patients remained on BDTX-1535 treatment for ≥4 months, 1 patient for ≥6 months, and 3 patients for ≥10 months
4ejppdo1ocsjbul994w9vfsmmp7p2b6pr4 1tjxdrsyhl
BNTX
GMAB
1 Jun 24
the risks and uncertainties described under the heading "Risk Factors" in BioNTech's Report on Form 6-K for the period ended March 31, 2024
78uhebz19v0l5ldb28z6sxipu26tn1qnsre8o1ga5uf ore
JAZZ
1 Jun 24
chemotherapy in second-line patients with advanced BTC is reported to be between 6-9 months1 so
9oglk
BMY
1 Jun 24
In the pooled safety population, 6% of 366 patients with at least one post-baseline electrocardiogram (ECG) assessment had an average
tqouzkl j1am
PFE
TAK
1 Jun 24
with previously untreated sALCL in combination with CHP and (6) for the treatment of adult patients with CD30-positive cutaneous T-cell lymphoma (CTCL
3611ru
IMCR
1 Jun 24
(IMCgp100-102), 25% (32/127) had any tumor reduction that was confirmed in at least one subsequent scan, including 6 partial responses (PR), an overall
m67stkr6n
CGEM
1 Jun 24
on Saturday, June 1, 2024, at 6:30 PM Central Time, during which Dr. Jeff Jones, Chief Medical Officer at Cullinan Therapeutics, will present an overview
k6jv3j21h2f66dvus0u6u wlx5akeujd8bktx7f6nqt5vv0r0
31 May 24
(K-12 and Higher education), Platform (Online and Offline), and Geography (North America, Europe, APAC, South America, and Middle East
m42fbmdeo1weuq1z4lhw2an4yr1bh0lqss49tf2pz3nwh 1zerhtg696gl9
31 May 24
regimen and formulation for amivantamab subcutaneous delivery.6
yllw0 yof6ms7080n0
CRGEQ
31 May 24
render the Company insolvent and unable to sustain its operations and continue as a going concern." On December 6, 2023, in a Form 8-K
vtin6mf3w4v0eri2yw9dwni9uctx70bhlktjmanu1bqlk o9ag
31 May 24
.6The Phase 3 MARIPOSA-2
7pqe 5pofwxqh9
AVB
31 May 24
from June 3 – 6, 2024. During this event, management may discuss the Company's current operating environment and trends; development, redevelopment
ytnb88vm3mwsfxtbrh4evnhnnjcnem4557b9ynfvvgfqlu
IMCR
31 May 24
/ 6:15 PM CT (OXFORDSHIRE, England & CONSHOHOCKEN, PA & ROCKVILLE, MD, US, 31 May 2024
0lavrtt37wub9i97g5
KDLY
31 May 24
disclosures, including the statements made under the heading "Risk Factors" in KindlyMD, Inc.'s Annual Report on Form 10-K for the fiscal year
dubwqq5yb1cmvmwm4hgb114p3lkjrkudwi30t
STLA
31 May 24
described in Stellantis' Annual Report on Form 20-F for the year ended December 31, 2023 and Current Reports on Form 6-K and amendments thereto filed
f251ubmjwwtl0ou4unzs6v vt40gugsrzax
KALV
31 May 24
Median time from attack onset to treatment was 41 min (Q1, 6; Q3, 140) with 55.7% of participants treating in less than 1 hour
0tlojhs0s8328 icf5bsc0be
CORBF
31 May 24
.
On April 29, 2022, after the market closed, in a Form 6-K filed with the SEC, Global Cord announced that it had entered
8ponihlll0ckgpcgaamrutjvk9557ipoonzn6ua nrpjiiqoyh
HGTY
31 May 24
, with the auction beginning at 6:30 pm. The auction will continue Thursday, the 15th with the sale beginning at 3:00 pm. Please visit
luk5it l1vdvk7h05rrq
31 May 24
acclaimed K-Beauty at a glance
- CJ Olive Young, a leading K-beauty retailer, to host its